Suchergebnisse - "Ana Pilar Gonzalez-Rodriguez"

PubPharm (5)

1

T098: Brentuximab Vedotin plus ESHAP (BRESHAP) versus ESHAP in Patients with Relapsed or Refractory Classical Hodgkin’s Lymphoma. Interim Results of the BRESELIBET Prospective Clinical Trial.

in: HemaSphere | 2022

von Anna Sureda-Balari | M. José Terol | Eva Domingo-Domènech | +21

2

Adjuvanted recombinant zoster vaccine in adult autologous stem cell transplant recipients: polyfunctional immune responses and lessons for clinical practice

in: Human Vaccines & Immunotherapeutics | 2021

von Edward A. Stadtmauer | Keith M. Sullivan | Mohamed El Idrissi | +27

3

Expansion of NK cells and reduction of NKG2D expression in chronic lymphocytic leukemia. Correlation with progressive disease.

in: PLoS ONE | 2014

von Leticia Huergo-Zapico | Andrea Acebes-Huerta | Ana Pilar Gonzalez-Rodriguez | +7

4

Lenalidomide Induces Immunomodulation in Chronic Lymphocytic Leukemia and Enhances Antitumor Immune Responses Mediated by NK and CD4 T Cells

in: BioMed Research International | 2014

von Andrea Acebes-Huerta | Leticia Huergo-Zapico | Ana Pilar Gonzalez-Rodriguez | +4

5

Lenalidomide and Chronic Lymphocytic Leukemia

in: BioMed Research International | 2013

von Ana Pilar González-Rodríguez | Angel R. Payer | Andrea Acebes-Huerta | +4

1
[1]